8.52072
Fmoc-Asp-OAll
Novabiochem®
Manufacturer: Sigma Aldrich
CAS Number: 144120-53-6
Synonym(S): Fmoc-Asp-OAll, N-α-Fmoc-L-aspartic acid α-allyl ester
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 1 G | 8.52072-1-G | In Stock | ₹ 6,780.01 |
| 5 G | 8.52072-5-G | In Stock | ₹ 26,440.00 |
8.52072 - 1 G
In Stock
Quantity
1
Base Price: ₹ 6,780.01
GST (18%): ₹ 1,220.402
Total Price: ₹ 8,000.412
Quality Level
200
product line
Novabiochem®
Assay
≥97.0% (acidimetric)≥98% (TLC)≥98.0% (HPLC)
form
powder
reaction suitability
reaction type: Fmoc solid-phase peptide synthesis
manufacturer/tradename
Novabiochem®
mp
95 °C (decomposes)
application(s)
peptide synthesis
functional group
carboxylic acid
storage temp.
2-30°C
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | Chem-Impex International, Inc. Fmoc-L-aspartic acid a-allyl ester | 144120-53-6 | MFCD00467715 | 5G | -- | ₹ 24,112.52 | |
| | Sigma Aldrich Fine Chemicals Biosciences Fmoc-Asp-OAll >=97.0% (HPLC) | 144120-53-6 | MFCD00467715 | 5G | -- | ₹ 59,447.09 | |
| | eMolecules Ambeed / Fmoc-Asp-OAll / 10g / 552618727 / A176715 / / 144120-53-6 / MFCD00467715 / 395.411 / C22H21NO6 | -- | ₹ 4,255.75 | |
| | STA PHARMACEUTICAL US LLC WuXi TIDES Fmoc-L-Asp-OAll | 144120-53-6, 1GR | -- | ₹ 1,796.76 | |
| | STA PHARMACEUTICAL US LLC WuXi TIDES Fmoc-L-Asp-OAll | 144120-53-6, 25GR | -- | ₹ 5,304.72 | |
| | Fmoc-Asp-OAll | -- | ₹ 38,742.68 | |
| | L-Aspartic acid, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-, 1-(2-propen-1-yl) ester | -- | ₹ 342.24 - ₹ 22,673.40 | |
| | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(allyloxy)-4-oxobutanoic acid | -- | ₹ 1,711.20 - ₹ 25,924.68 |
Related Products
Description
- General description: Orthogonally-protected building block for the synthesis of head-to-tail cyclic peptides [1,2,3,4,5] by Fmoc SPPS. The α-allyl ester can be selectively removed in the presence of Fmoc- and tBu-based protecting groups by treatment with Pd(Ph3P)4/ CHCl3/AcOH/NMM [6], thereby facilitating the synthesis of branched esters, amides, lactones and lactams incorporating an aspartyl unit. Associated Protocols and Technical ArticlesCleavage and Deprotection Protocols for Fmoc SPPSLiterature references[1] W. Bannwarth, et al. (1992) Tetrahedron Lett., 33, 4557. [2] F. Albericio, et al. (1993) Tetrahedron Lett., 34, 1549. [3] J. Eichler, et al. (1994) Pept. Res., 7, 300. [4] J. Eichler, et al. in ′Peptides 1994, Proc. 23rd European Peptide Symposium′, H. Maia (Eds), ESCOM, Leiden, 1994, pp. 461. [5] J. Eichler, et al. in ′Solid Phase Synthesis & Combinatorial Libraries, 4th International Symposium′, R. Epton (Eds), Mayflower Scientific Ltd., Birmingham, 1996, pp. 201. [6] S. A. Kates, et al. in ′Peptides, Chemistry, Structure & Biology, Proc. 13th American Peptide Symposium′, ESCOM, Leiden, 1994, pp. 113.
- Linkage: Replaces: 04-12-1157
- Analysis Note: Color (visual): white to slight yellow to beigeAppearance of substance (visual): powderIdentity (IR): conformsEnantiomeric purity: ≥ 99.0 % (a/a)Purity (TLC(CMA2)): ≥ 98 %Purity (TLC(157A)): ≥ 98 %Assay (HPLC, area%): ≥ 98.0 % (a/a)Solubility (1 mmole in 2 ml DMF): clearly solubleAssay (acidimetric): ≥ 97.0 %Water (K. F.): ≤ 1.5 %To see the solvent systems used for TLC of Novabiochem® products please click here.
- Legal Information: Novabiochem is a registered trademark of Merck KGaA, Darmstadt, Germany
SAFETY INFORMATION
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable